LF1 and BGLF1 EBV gene transcript sequences were expressed in 88% and 53% of the BC tumors, respectively, with no expression detected in normal control breast tissues; both gene transcript sequences were preferentially expressed in 80% of HER2+ BC tumors at approximately two-fold higher levels as compared to the average values of all tumors. The gene discussed is ERBB2; the disease is breast cancer.